haemophilus influenzae type b capsular polysaccharide prp
SpainDrugs containing this active substance
-
It is a vaccine that helps protect children from six weeks of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg haemophilus influenzae type b capsular polysaccharide prp 12 µg Manufacturer: Sanofi Winthrop Industrie
-
It is a vaccine that helps protect children from six weeks of age against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg haemophilus influenzae type b capsular polysaccharide prp 12 µg Manufacturer: Sanofi Winthrop Industrie